Study on Bioequivalence of Ambroxol Hydrochloride Oral Disintegrating Tablets in Healthy Volunteers
Chang Shik Hong
Abstract
Chang Shik Hong
Abstract
OBJECTIVE:To study the bioequivalence of Ambroxol hydrochloride oral disintegrating tablets in healthy volunteers after significant change of manufacturing technology.METHODS:Test preparation and reference preparation each 30 mg were given to 20 male healthy volunteers in randomized two-way crossover design.Blood samples were collected within 48 h after medication using pramipexole as internal standard.Plasma concentrations of ambroxol hydrochloride were determined by LC-MS,and pharmacokinetic parameters were analyzed using DAS 2.0 software.RESULTS:The pharmacokinetics parameters of test preparation and reference preparation were as follows:cmax(84.96±32.46)ng/ml and(90.86±44.81) ng/ml;tmax(1.7±0.7) h and(1.4±0.3) h;AUC0-48 h(678.85±235.17) ng·h/ml and(663.87±214.37)ng·h/ml;t1/2(9.8±1.9) h and(9.7±2.0)h,respectively.There was no significant difference in main pharmacokinetic parameters of them.CONCLUSIONS:Two preparations are bioequivalent after significant change of manufacturing technology.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE:To study the bioequivalence of Ambroxol hydrochloride oral disintegrating tablets in healthy volunteers after significant change of manufacturing technology.METHODS:Test preparation and reference preparation each 30 mg were given to 20 male healthy volunteers in randomized two-way crossover design.Blood samples were collected within 48 h after medication using pramipexole as internal standard.Plasma concentrations of ambroxol hydrochloride were determined by LC-MS,and pharmacokinetic parameters were analyzed using DAS 2.0 software.RESULTS:The pharmacokinetics parameters of test preparation and reference preparation were as follows:cmax(84.96±32.46)ng/ml and(90.86±44.81) ng/ml;tmax(1.7±0.7) h and(1.4±0.3) h;AUC0-48 h(678.85±235.17) ng·h/ml and(663.87±214.37)ng·h/ml;t1/2(9.8±1.9) h and(9.7±2.0)h,respectively.There was no significant difference in main pharmacokinetic parameters of them.CONCLUSIONS:Two preparations are bioequivalent after significant change of manufacturing technology.
Key concepts: Bioequivalence, Cmax, Pharmacokinetics, Ambroxol, Crossover study, Pharmacology, Hydrochloride, Chromatography